These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 38411876)

  • 1. Role of the Microbiome in the Diagnosis and Management of Gastroesophageal Cancers.
    Mascaretti F; Haider S; Amoroso C; Caprioli F; Ramai D; Ghidini M
    J Gastrointest Cancer; 2024 Jun; 55(2):662-678. PubMed ID: 38411876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma.
    Lv J; Guo L; Liu JJ; Zhao HP; Zhang J; Wang JH
    World J Gastroenterol; 2019 May; 25(18):2149-2161. PubMed ID: 31143067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of
    Guo Y; Zhang Y; Gerhard M; Gao JJ; Mejias-Luque R; Zhang L; Vieth M; Ma JL; Bajbouj M; Suchanek S; Liu WD; Ulm K; Quante M; Li ZX; Zhou T; Schmid R; Classen M; Li WQ; You WC; Pan KF
    Gut; 2020 Sep; 69(9):1598-1607. PubMed ID: 31857433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiome in reflux disorders and esophageal adenocarcinoma.
    Yang L; Chaudhary N; Baghdadi J; Pei Z
    Cancer J; 2014; 20(3):207-10. PubMed ID: 24855009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics mitigate Helicobacter pylori-induced gastric inflammation and premalignant lesions in INS-GAS mice with the modulation of gastrointestinal microbiota.
    He C; Peng C; Xu X; Li N; Ouyang Y; Zhu Y; Lu N
    Helicobacter; 2022 Aug; 27(4):e12898. PubMed ID: 35531615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal microbiome and
    Sitkin S; Lazebnik L; Avalueva E; Kononova S; Vakhitov T
    World J Gastroenterol; 2022 Feb; 28(7):766-774. PubMed ID: 35317277
    [No Abstract]   [Full Text] [Related]  

  • 7. Suicide journey of H. pylori through gastric carcinogenesis: the role of non-H. pylori microbiome and potential consequences for clinical practice.
    de Assumpção PP; Araújo TMT; de Assumpção PB; Barra WF; Khayat AS; Assumpção CB; Ishak G; Nunes DN; Dias-Neto E; Coelho LGV
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1591-1597. PubMed ID: 31114971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.
    Sobocki BK; Kaźmierczak-Siedlecka K; Folwarski M; Hawryłkowicz V; Makarewicz W; Stachowska E
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter to the Editor: Comment on: Role of the Microbiome in the Diagnosis and Management of Gastroesophageal Cancers.
    Kountouras J; Kazakos E; Polyzos SA; Zavos C
    J Gastrointest Cancer; 2024 Jun; 55(2):679-680. PubMed ID: 38587610
    [No Abstract]   [Full Text] [Related]  

  • 10. Restoration of dysbiotic human gut microbiome for homeostasis.
    Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
    Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Gut Microbiota and
    Gao JJ; Zhang Y; Gerhard M; Mejias-Luque R; Zhang L; Vieth M; Ma JL; Bajbouj M; Suchanek S; Liu WD; Ulm K; Quante M; Li ZX; Zhou T; Schmid R; Classen M; Li WQ; You WC; Pan KF
    Front Cell Infect Microbiol; 2018; 8():202. PubMed ID: 29971220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut dysbacteriosis and intestinal disease: mechanism and treatment.
    Meng X; Zhang G; Cao H; Yu D; Fang X; de Vos WM; Wu H
    J Appl Microbiol; 2020 Oct; 129(4):787-805. PubMed ID: 32277534
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Yang L; Zhang J; Xu J; Wei X; Yang J; Liu Y; Li H; Zhao C; Wang Y; Zhang L; Gai Z
    Front Cell Infect Microbiol; 2019; 9():375. PubMed ID: 31781514
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
    Haak BW; Prescott HC; Wiersinga WJ
    Front Immunol; 2018; 9():2042. PubMed ID: 30250472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the complex role of gut microbiome in the development of precision medicine strategies for targeting microbial imbalance-induced colon cancer.
    Pal P; Shastry RP
    Folia Microbiol (Praha); 2023 Oct; 68(5):691-701. PubMed ID: 37624549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review.
    Yousef M; Rob M; Varghese S; Rao S; Zamir F; Paul P; Chaari A
    Life Sci; 2024 Apr; 342():122535. PubMed ID: 38408636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gut microbiota: What impact on colorectal carcinogenesis and treatment?].
    Bruneau A; Baylatry MT; Joly AC; Sokol H
    Bull Cancer; 2018 Jan; 105(1):70-80. PubMed ID: 29217301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer.
    Fong W; Li Q; Yu J
    Oncogene; 2020 Jun; 39(26):4925-4943. PubMed ID: 32514151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal microbiome in the context of Helicobacter pylori infection in stomach and gastroduodenal diseases.
    Retnakumar RJ; Nath AN; Nair GB; Chattopadhyay S
    Prog Mol Biol Transl Sci; 2022; 192(1):53-95. PubMed ID: 36280325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development.
    Doocey CM; Finn K; Murphy C; Guinane CM
    BMC Microbiol; 2022 Feb; 22(1):53. PubMed ID: 35151278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.